From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 517,399 shares, representing 3.5% for $0.63 million under the buyback announced on November 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1171 USD | +0.69% | -1.60% | -40.86% |
Apr. 11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 13 | Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-40.86% | 2.61M | |
-4.24% | 86.85B | |
+2.76% | 40.16B | |
-16.59% | 31.28B | |
+57.86% | 25.27B | |
-15.26% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+6.89% | 8.83B | |
-10.53% | 7.94B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.